Literature DB >> 18508490

The role of chemokines in glomerulonephritis.

Takashi Wada1, Kouji Matsushima, Shuichi Kaneko.   

Abstract

Leukocyte infiltration to glomeruli plays an essential role in the pathogenesis of glomerulonephritis. Pathophysiological roles of chemokines and their cognate receptors have shed light on the detailed molecular mechanisms of leukocyte trafficking and activation both in clinical and experimental settings of glomerulonephritis. Infiltrating leukocytes and glomerular resident cells interact to promote and exacerbate glomerular injury, eventually leading to glomerulosclerosis. Further, recent studies on chemokines have expanded their universe beyond leukocyte migration to glomeruli, to include homeostasis, development and protection of resident cells in glomeruli. New insights into proteinuria have been uncovered by the regulation of chemokine system. The intervention of chemokines and their cognate receptors may have therapeutic potential to slow the progression of glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508490     DOI: 10.2741/2984

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  11 in total

1.  Coming of Age--CC Chemokine Ligand 18 in ANCA-Associated Vasculitis.

Authors:  Renate Kain; Andrew J Rees
Journal:  J Am Soc Nephrol       Date:  2015-03-11       Impact factor: 10.121

2.  Purple corn anthocyanins retard diabetes-associated glomerulosclerosis in mesangial cells and db/db mice.

Authors:  Jing Li; Min-Kyung Kang; Jin-Kyu Kim; Jung-Lye Kim; Sang-Wook Kang; Soon Sung Lim; Young-Hee Kang
Journal:  Eur J Nutr       Date:  2011-11-20       Impact factor: 5.614

3.  Use of ultrasound to assess renal reperfusion and P-selectin expression following unilateral renal ischemia.

Authors:  Erika I Boesen; G Ryan Crislip; Jennifer C Sullivan
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-29

Review 4.  Mesangial pathology in glomerular disease: targets for therapeutic intervention.

Authors:  Yogesh M Scindia; Umesh S Deshmukh; Harini Bagavant
Journal:  Adv Drug Deliv Rev       Date:  2010-09-07       Impact factor: 15.470

5.  Exploring the mechanism of Jianpi Qushi Huayu Formula in the treatment of chronic glomerulonephritis based on network pharmacology.

Authors:  Tao Liu; Ya Chen Gao; Xiu Juan Qin; Jia Rong Gao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-10-07       Impact factor: 3.000

6.  Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis.

Authors:  L M McIntosh; J L Barnes; V L Barnes; J R McDonald
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

Review 7.  The Changing Landscape of Renal Inflammation.

Authors:  Thomas Ernandez; Tanya Norton Mayadas
Journal:  Trends Mol Med       Date:  2016-01-07       Impact factor: 11.951

8.  CCL2/CCR2 augments the production of transforming growth factor-beta1, type 1 collagen and CCL2 by human CD45-/collagen 1-positive cells under high glucose concentrations.

Authors:  Akinori Hara; Norihiko Sakai; Kengo Furuichi; Yoshio Sakai; Motohiro Takeya; Richard Bucala; Naofumi Mukaida; Yoh Takuwa; Kouji Matsushima; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-04-06       Impact factor: 2.801

9.  Homocysteine-induced macrophage inflammatory protein-2 production by glomerular mesangial cells is mediated by PI3 Kinase and p38 MAPK.

Authors:  Suresh Shastry; Leighton R James
Journal:  J Inflamm (Lond)       Date:  2009-09-26       Impact factor: 4.981

Review 10.  Role of Chemokine (C-X-C Motif) Ligand 10 (CXCL10) in Renal Diseases.

Authors:  Jie Gao; Lingling Wu; Siyang Wang; Xiangmei Chen
Journal:  Mediators Inflamm       Date:  2020-02-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.